Compare TFII & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TFII | ALGN |
|---|---|---|
| Founded | 1957 | 1997 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 10.5B |
| IPO Year | 2012 | 2000 |
| Metric | TFII | ALGN |
|---|---|---|
| Price | $111.81 | $149.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 16 |
| Target Price | $157.64 | ★ $193.79 |
| AVG Volume (30 Days) | 282.7K | ★ 848.5K |
| Earning Date | 10-29-2026 | 10-28-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | N/A | ★ 3.09 |
| Revenue | N/A | ★ $387,126,000.00 |
| Revenue This Year | $9.40 | $2.95 |
| Revenue Next Year | $4.99 | $3.76 |
| P/E Ratio | ★ $31.26 | $48.31 |
| Revenue Growth | N/A | ★ 23.95 |
| 52 Week Low | $80.63 | $130.23 |
| 52 Week High | $167.69 | $200.44 |
| Indicator | TFII | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 30.03 | 53.07 |
| Support Level | $106.20 | $138.05 |
| Resistance Level | $113.76 | $154.10 |
| Average True Range (ATR) | 3.29 | 3.59 |
| MACD | 0.22 | 1.44 |
| Stochastic Oscillator | 9.36 | 79.00 |
TFI International Inc is involved in the provision of transportation and logistics services across the United States, Canada, and Mexico. The company's reportable segments are; Less-Than-Truckload, which derives maximum revenue, Truckload, and Logistics. The Less-Than-Truckload segment engages in pickup, consolidation, transport, and delivery of smaller loads; the Truckload segment deals with full loads carried directly from the customer to the destination using a closed van or specialized equipment to meet customer's specific needs; and the Logistics segment provides asset-light logistics services, including brokerage, freight forwarding, and transportation management, as well as small package parcel delivery. Geographically, the company generates maximum revenue from the United States.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.